MedTrace Logo

Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy

NCT00917553 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2018-11-30

Study results available
· View outcomes & findings →

Summary

This 24 month randomized research study will evaluate whether doxycycline can slow the deterioration or improve retinal function among patients with mild to moderate non-proliferative diabetic retinopathy.

Conditions

Interventions

DRUG

doxycycline monohydrate

50 mg

DRUG

Placebo

Cellulose Placebo Capsule

Sponsors & Collaborators

  • Penn State University

    collaborator OTHER

  • Juvenile Diabetes Research Foundation

    collaborator OTHER

  • Thomas Gardner

    lead OTHER

Principal Investigators

  • Thomas W Gardner, MD.,MS. · University of Michigan, Kellogg Eye Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00917553 on ClinicalTrials.gov